Headline RoundupJuly 27th, 2020

Moderna, NIH Advance Coronavirus Vaccine Trials

Summary from the AllSides News Team

In partnership with the National Institutes of Health, biotechnology company Moderna plans to enroll roughly 30,000 subjects in Phase 3 of its COVID-19 coronavirus vaccine trial. The Biomedical Advanced Research and Development Authority have awarded Moderna another $472 million to fill the gap in needed funds. This brings the company's U.S.-based financial backing to roughly $955 million. Reporting on the matter has been consistent regardless of media bias ratings or purported political leanings.

Featured Coverage of this Story

More headline roundups

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right